Search BRITE hierarchies

Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
  A ALIMENTARY TRACT AND METABOLISM
    A10 DRUGS USED IN DIABETES
      A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
        A10BJ Glucagon-like peptide-1 (GLP-1) analogues [DG:DG01493]
          A10BJ02 Liraglutide
            D06404  Liraglutide (USAN/INN) <JP/US>

USP drug classification [BR:br08302]
  Anti-Obesity Agents
    Liraglutide
      D06404  Liraglutide (USAN/INN)
  Blood Glucose Regulators
    Antidiabetic Agents
      GLP-1 Receptor Agonist
        Liraglutide
          D06404  Liraglutide (USAN/INN)

Therapeutic category of drugs in Japan [BR:br08301]
  2  Agents affecting individual organs
    24  Hormones
      249  Miscellaneous
        2499  Others
          D06404  Liraglutide (USAN/INN); Liraglutide (genetical recombination) (JAN)

Drug groups [BR:br08330]
  Antidiabetic agent
    DG02044  Hypoglycemic agent
      DG01493  GLP-1 receptor agonist
        D06404  Liraglutide

Drug classes [BR:br08332]
  Antidiabetic agent
    DG01493  GLP-1 receptor agonist
      D06404  Liraglutide
    DG02044  Hypoglycemic agent
      D06404  Liraglutide

Target-based classification of drugs [BR:br08310]
  G Protein-coupled receptors
    Secretin receptor family
      Glucagon
        GLP1R [HSA:2740] [KO:K04581]
          D06404  Liraglutide (USAN/INN) <JP/US>

New drug approvals in the USA [br08319.html]
  D06404

New drug approvals in Europe [br08329.html]
  D06404

New drug approvals in Japan [br08318.html]
  D06404

New drug approvals in the USA, Europe and Japan [br08328.html]
  D06404